<DOC>
	<DOCNO>NCT01073618</DOCNO>
	<brief_summary>This non-interventional study voriconazole IV formulation clinical use , mandated Korean government agency follow approval Vfend Republic Korea .</brief_summary>
	<brief_title>Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of VfendÂ® IV</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Invasive aspergillosis serious fungal infection .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>voriconazole</keyword>
	<keyword>Korea</keyword>
	<keyword>invasive fungal infection</keyword>
</DOC>